Emerging Topics in Clostridioides difficile Infection: A One Health Problem
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 4003
Special Issue Editor
Special Issue Information
Dear Colleagues,
Clostridium difficile infection (CDI) remains a substantial worldwide burden on healthcare systems, despite significant research and investment over the past four decades. We extend a warm invitation for comprehensive studies focusing on C. difficile isolation, characterization, and epidemiology in humans, animals, and the environment.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: AMR transmission and assessment, environmental sampling, animal transmission/infection studies, antimicrobial prescribing studies and their effect on C. difficile infection, transmission and carriage in humans and animals, and assessment of C. difficile contamination of foodstuffs. We also welcome submissions involving fundamental science laboratory studies, in vivo animal and human studies, or modeling studies.
We look forward to receiving your contributions.
Dr. Simon D. Baines
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- clostridium difficile infection (CDI)
- antimicrobial resistance (AMR)
- antimicrobial prescribing
- one health
- laboratory studies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.